Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR | Q13258 | 6/20 | 0.59 |
| ▸ | RBP4 | P02753 | 1/20 | 0.46 |
| ▸ | PTGDR2 | Q9Y5Y4 | 7/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KMO | O15229 | 1/20 | 0.44 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | RORC | P51449 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7433243 | 0.79 | FFAR1 (0.50) | PTGDR2FFAR1MAPTTDP1 | |
| SCHEMBL30819586 | 0.79 | MAPT (0.51) | PTGDRMAPTRORC | |
| SCHEMBL19522397 | 0.78 | KMT2A (0.49) | PTGDRFFAR1MAPTTDP1CHRM1 | |
| SCHEMBL3813636 | 0.78 | PTGDR (0.57) | PTGDRRBP4PTGDR2FFAR1FFAR4 | |
| SCHEMBL31717890 | 0.76 | PLAU (0.51) | PTGDRKMOFFAR4 | |
| SCHEMBL30819610 | 0.75 | SLC6A4 (0.40) | PTGDR | |
| SCHEMBL32689809 | 0.75 | PTGDR (0.44) | PTGDRPTGDR2FFAR1MAPTTDP1 | |
| SCHEMBL929640 | 0.74 | GRIK1 (0.62) | KMORORC | |
| Hydrochloric Acid SCHEMBL2777981 | 0.74 | PTGDR (0.53) | PTGDRRBP4FFAR1HRH1FFAR4 | |
| SCHEMBL3405256 | 0.74 | THRA (0.56) | PTGDRPTGER2HRH1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712969-A1 | CYCLIN INHIBITORS | Circle Pharma, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |